Atlas Trials

A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC

Clinical trial NCT04102124 · TERMINATED

Trial details

NCT number
NCT04102124
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerCastration-resistant Prostate Cancer
Start date
2019-04-08
Primary completion
2021-08-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.